EAM
Eagle Asset Management Portfolio holdings
AUM
$19.6B
This Quarter Return
+6.49%
1 Year Return
+41.7%
3 Year Return
+53.51%
5 Year Return
+214.43%
10 Year Return
+692.81%
AUM
$17.4B
AUM Growth
+$17.4B
(+5.3%)
Cap. Flow
+$88.6M
Cap. Flow
% of AUM
0.51%
Top 10 Holdings %
Top 10 Hldgs %
11.17%
Holding
673
New
42
Increased
346
Reduced
192
Closed
56
Top Buys
| 1 |
DuPont de Nemours
DD
|
$94.3M |
| 2 |
Texas Capital Bancshares
TCBI
|
$59.9M |
| 3 |
Progressive
PGR
|
$56.4M |
| 4 |
MDSO
Medidata Solutions, Inc.
MDSO
|
$49.5M |
| 5 |
KITE
Kite Pharma, Inc.
KITE
|
$46.7M |
Top Sells
| 1 |
Bank OZK
OZK
|
$85.3M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
$85.2M |
| 3 |
Integra LifeSciences
IART
|
$75.4M |
| 4 |
WBMD
WebMD Health Corp.
WBMD
|
$65.5M |
| 5 |
NXTM
NxStage Medical Inc.
NXTM
|
$64.5M |
Sector Composition
| 1 | Technology | 18.38% |
| 2 | Healthcare | 17.3% |
| 3 | Industrials | 17.02% |
| 4 | Consumer Discretionary | 12.1% |
| 5 | Financials | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Chart Industries
GTLS
$8.96B
| $58.3M | 0.33% |
1,448,392
+924,284
| +176% | +$37.2M |
|
102
Camden Property Trust
CPT
$12B
| $58.3M | 0.33% |
640,145
+5,856
| +0.9% | +$533K |
|
103
Monster Beverage
MNST
$60.9B
| $58.1M | 0.33% |
1,052,801
+187,238
| +22% | +$10.3M |
|
104
Intuitive Surgical
ISRG
$170B
| $58M | 0.33% |
54,680
-2,492
| -4% | -$2.64M |
|
105
Lennar Class A
LEN
$34.5B
| $56.9M | 0.33% |
1,076,505
+29,016
| +3% | +$1.53M |
|
|
AIMT
106
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $56.4M | 0.32% |
2,242,291
-27,869
| -1% | -$701K |
|
|
IMPV
107
DELISTED
Imperva, Inc.
IMPV
| $55.9M | 0.32% |
1,294,651
+14,803
| +1% | +$639K |
|
|
CAVM
108
DELISTED
Cavium, Inc.
CAVM
| $55.8M | 0.32% |
807,126
-1,874
| -0.2% | -$129K |
|
|
AET
109
DELISTED
Aetna Inc
AET
| $54.8M | 0.31% |
341,302
-1,733
| -0.5% | -$278K |
|
110
TransUnion
TRU
$16.8B
| $54.6M | 0.31% |
1,149,826
+202,797
| +21% | +$9.63M |
|
111
Aptiv
APTV
$17.3B
| $53.2M | 0.3% |
531,835
-85,646
| -14% | -$8.56M |
|
112
SBA Communications
SBAC
$22B
| $52.9M | 0.3% |
370,586
+9,032
| +2% | +$1.29M |
|
113
Omnicell
OMCL
$1.5B
| $52.2M | 0.3% |
998,107
+127,873
| +15% | +$6.69M |
|
114
Citigroup
C
$178B
| $52M | 0.3% |
704,924
+3,552
| +0.5% | +$262K |
|
115
Penumbra
PEN
$10.6B
| $52M | 0.3% |
563,290
+52,372
| +10% | +$4.83M |
|
116
Darling Ingredients
DAR
$5.37B
| $51.8M | 0.3% |
2,888,555
+50,174
| +2% | +$900K |
|
117
Zoetis
ZTS
$69.3B
| $51.5M | 0.3% |
808,160
+62,538
| +8% | +$3.99M |
|
118
Constellation Brands
STZ
$26.7B
| $51.1M | 0.29% |
256,276
+6,564
| +3% | +$1.31M |
|
119
Idexx Laboratories
IDXX
$51.8B
| $50.6M | 0.29% |
321,693
+4,043
| +1% | +$635K |
|
120
Veeco
VECO
$1.48B
| $50.3M | 0.29% |
2,376,122
-104,076
| -4% | -$2.2M |
|
121
Cooper Companies
COO
$13.4B
| $50.2M | 0.29% |
208,547
+7,113
| +4% | +$1.71M |
|
122
Encompass Health
EHC
$12.3B
| $50M | 0.29% |
1,088,131
-13,932
| -1% | -$640K |
|
|
ELLI
123
DELISTED
Ellie Mae Inc
ELLI
| $50M | 0.29% |
596,868
-6,349
| -1% | -$532K |
|
124
Genesco
GCO
$345M
| $49.9M | 0.29% |
1,882,561
-182,247
| -9% | -$4.83M |
|
125
Sarepta Therapeutics
SRPT
$1.9B
| $49.9M | 0.29% |
1,006,222
+207,810
| +26% | +$10.3M |
|